Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $244,700 - $272,297
-5,935 Closed
0 $0
Q4 2020

Feb 17, 2021

SELL
$33.15 - $41.97 $8,784 - $11,122
-265 Reduced 4.27%
5,935 $213,000
Q2 2020

Aug 17, 2020

SELL
$30.19 - $39.11 $1,358 - $1,759
-45 Reduced 0.72%
6,200 $218,000
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $9,040 - $15,998
-350 Reduced 5.31%
6,245 $204,000
Q3 2019

Nov 14, 2019

SELL
$40.31 - $43.45 $14,108 - $15,207
-350 Reduced 5.04%
6,595 $268,000
Q4 2018

Feb 14, 2019

BUY
$31.73 - $39.04 $30,460 - $37,478
960 Added 16.04%
6,945 $245,000
Q3 2018

Nov 14, 2018

SELL
$32.83 - $38.63 $91,759 - $107,970
-2,795 Reduced 31.83%
5,985 $230,000
Q2 2018

Aug 10, 2018

SELL
$26.84 - $34.32 $3,220 - $4,118
-120 Reduced 1.35%
8,780 $287,000
Q1 2018

May 04, 2018

SELL
$25.2 - $28.54 $12,600 - $14,270
-500 Reduced 5.32%
8,900 $243,000
Q3 2017

Oct 27, 2017

BUY
$26.26 - $29.17 $246,844 - $274,198
9,400
9,400 $274,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Van Cleef Asset Management,Inc Portfolio

Follow Van Cleef Asset Management,Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Cleef Asset Management,Inc, based on Form 13F filings with the SEC.

News

Stay updated on Van Cleef Asset Management,Inc with notifications on news.